AZN Operating Expenses

AstraZeneca PLC Ordinary Shares · Operating Expenses

AZN logo

AZN Operating Expenses

Latest reported$36.28B
AZN TTM Operating Expenses ($6.57B → $36.28B)
High-resolution chart · PNG

AZN operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
36,275,000,000
35,054,000,000
34,363,000,000
35,086,000,000
34,657,000,000
34,190,000,000
33,863,000,000
32,215,000,000
31,280,000,000
30,271,000,000
29,350,000,000
28,081,000,000
27,393,000,000
27,627,000,000
28,203,000,000
28,668,000,000
29,696,000,000
27,364,000,000
23,924,000,000
20,644,000,000
16,898,000,000
16,003,000,000
16,156,000,000
16,467,000,000
16,728,000,000
16,988,000,000
16,539,000,000
15,533,000,000
14,571,000,000
13,684,000,000
13,767,000,000
13,930,000,000
14,428,000,000
14,224,000,000
14,470,000,000
12,496,000,000
12,433,000,000
13,495,000,000
13,974,000,000
16,124,000,000
16,087,000,000
16,166,000,000
15,948,000,000
17,271,000,000
18,190,000,000
18,219,000,000
18,535,000,000
19,165,000,000
17,818,000,000
17,187,000,000
16,738,000,000
14,663,000,000
14,609,000,000
14,340,000,000
14,432,000,000
15,389,000,000
14,495,000,000
15,032,000,000
14,770,000,000
14,340,000,000
15,950,000,000
15,659,000,000
15,386,000,000
15,894,000,000
15,659,000,000
15,610,000,000
15,486,000,000
14,720,000,000
14,655,000,000
15,064,000,000
15,859,000,000
15,770,000,000
15,825,000,000
15,604,000,000
15,046,000,000
14,519,000,000
13,867,000,000
13,139,000,000
12,646,000,000
12,335,000,000
12,113,000,000
12,111,000,000
12,092,000,000
16,135,000,000
16,093,000,000
15,977,000,000
15,961,000,000
11,625,000,000
11,331,700,081
10,801,162,890
10,268,999,999
10,238,043,668
9,934,680,927
9,668,218,118
9,291,381,009
15,149,543,802
14,810,206,462
14,669,206,462
14,595,092,215
11,396,751,723
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.